Abstract The present invention discloses a novel method for preparing crosslinked biomaterial compositions for use in the augmentation of soft or hard tissue. In general, the method comprises mixing a biocompatible polymer, which is preferably collagen, with a sterile, dry crosslinking agent, which is preferably a synthetic hydrophilic polymer such as a functionally activated polyethylene glycol. Also provided are preferred processes for preparing sterile, dry crosslinking agents contained within syringes for use in the method of the invention. Methods for sterilization of the crosslinking agent include, but are not limited to, sterile filtration, aseptic processing, and e-beam or gamma irradiation. Methods for providing augmentation of soft or hard tissue using crosslinked biomaterial compositions prepared according to the method of the invention are also disclosed.
A process for preparing a sterile, dry crosslinking agent comprising molding a dry crosslinking agent to form a pellet and sterilizing the pellet using e-beam irradiation, wherein the crosslinking agent is a functionally activated polyethylene glycol.
Claim 2
Dependent Claim
36 words
A process for preparing a sterile, dry crosslinking agent comprising molding a dry crosslinking agent to form a pellet and sterilizing the pellet using e-beam irradiation, wherein the crosslinking agent is a functionally activated polyethylene glycol.
Claim 3
Dependent Claim
17 words
The process of claim 1, wherein the functionally activated polyethylene glycol is a difunctionally activated polyethylene glycol.
Claim 4
Dependent Claim
16 words
The process of claim 1, wherein the pellet is dispensed into a syringe prior to irradiation.
Claim 5
Dependent Claim
21 words
The process of claim 1, wherein the radiation dosage is within the range of about 0.5 Mrad to about 4 Mrad.
Claim 6
Dependent Claim
21 words
The process of claim 4, wherein the e-beam irradiation is within the range of about 1.5 Mrad to about 2.5 Mrad.